Want to join the conversation?
Pharma companies $REGN and Sanofi said they finished enrollment in global Phase 3 Odyssey outcomes trial, which evaluates potential cardiovascular benefits of Praluent Injection after an acute coronary syndrome. The 18,000-patient trial is expected to be completed in 2017.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!